Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation

Publisher： Karger

E-ISSN： 1662-6575|6|3|585-592

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.3, 2013-11, pp. : 585-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 286-295

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4158-4164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre-Emptive Treatment with Nilotinib after Second Allogeneic Transplantation in a Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patient with High Risk of Relapse

By  

Acta Haematologica, Vol. 123, Iss. 4, 2010-05 ,pp. : 242-247

Karger

Access to resources Recommend Favorite

Imatinib Treatment Alone in Philadelphia-Positive Acute Lymphoblastic Leukemia: Is It Enough

By  

Case Reports in Oncology, Vol. 4, Iss. 2, 2011-06 ,pp. : 323-326

Karger

Access to resources Recommend Favorite